The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
Open accessAbstract
IMPORTANCE: New data and therapeutic options warrant updated recommendations for the use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. OBJECTIVE: To provide updated recommendations for the use of antiretroviral therapy in adults (aged ≥18 years) with established HIV infection, including when to start treatment, initial regimens, and changing regimens, along with recommendations for using ARVs for preventing HIV among those at risk, including preexposure and postexposure prophylaxis. EVIDENCE REVIEW: A panel of experts in HIV research and patient care convened by the International Antiviral Society-USA reviewed data published in peer-reviewed journals, presented by regulatory agencies, or presented as conference abstracts at peer-reviewed scientific conferences since the 2014 report, for new data or evidence that would change previous recommendations or their ratings. Comprehensive literature searches were conducted in the PubMed and EMBASE databases through April 2016. Recommendations were by consensus, and each recommendation was rated by strength and quality of the evidence. FINDINGS: Newer data support the widely accepted recommendation that antiretroviral therapy should be started in all individuals with HIV infection with detectable viremia regardless of CD4 cell count. Recommended optimal initial regimens for most patients are 2 nucleoside reverse transcriptase inhibitors (NRTIs) plus an integrase strand transfer inhibitor (InSTI). Other effective regimens include nonnucleoside reverse transcriptase inhibitors or boosted protease inhibitors with 2 NRTIs. Recommendations for special populations and in the settings of opportunistic infections and concomitant conditions are provided. Reasons for switching therapy include convenience, tolerability, simplification, anticipation of potential new drug interactions, pregnancy or plans for pregnancy, elimination of food restrictions, virologic failure, or drug toxicities. Laboratory assessments are recommended before treatment, and monitoring during treatment is recommended to assess response, adverse effects, and adherence. Approaches are recommended to improve linkage to and retention in care are provided. Daily tenofovir disoproxil fumarate/emtricitabine is recommended for use as preexposure prophylaxis to prevent HIV infection in persons at high risk. When indicated, postexposure prophylaxis should be started as soon as possible after exposure. CONCLUSIONS AND RELEVANCE: Antiretroviral agents remain the cornerstone of HIV treatment and prevention. All HIV-infected individuals with detectable plasma virus should receive treatment with recommended initial regimens consisting of an InSTI plus 2 NRTIs. Preexposure prophylaxis should be considered as part of an HIV prevention strategy for at-risk individuals. When used effectively, currently available ARVs can sustain HIV suppression and can prevent new HIV infection. With these treatment regimens, survival rates among HIV-infected adults who are retained in care can approach those of uninfected adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Self-citationPreexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M. J., VanDyke, R., Bey, M., Shearer, W., Jacobson, R. L., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311801 · Cited by 3,705
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
(2006) · PsycEXTRA Dataset · doi:10.1037/e545592006-001 · Cited by 2,958
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506816 · Cited by 2,798
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,698
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Self-citationCD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Self-citationCenters for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Tebas, P., Stein, D., Tang, W. W., Frank, I., Wang, S. Q., Lee, G., Spratt, S. K., Surosky, R. T., Giedlin, M. A., Nichol, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300662 · Cited by 1,357
Lester, R. T., Ritvo, P., Mills, E. J., Kariri, A., Karanja, S., Chung, M. H., Jack, W., Habyarimana, J., Sadatsafavi, M., Najafzadeh, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61997-6 · Cited by 1,278
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,242
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapia, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,208
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citationTreatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Self-citationCarpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., et al. (2000) · JAMA · doi:10.1001/jama.283.3.381 · Cited by 1,012
Self-citationCarpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., et al. (1998) · JAMA · doi:10.1001/jama.280.1.78 · Cited by 995
Self-citationDonnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., McIntyre, J., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 952
Le, M., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J. M., Bocchini, J. A., & Unger, E. R. (2014) · PubMed · Cited by 924
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
Walmsley, S. L., Antela, A., Clumeck, N., Duiculescu, D., Eberhard, A., Gutiérrez, F., Hocqueloux, L., Maggiolo, F., Sandkovsky, U., Granier, C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215541 · Cited by 876
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Self-citationThe Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Use of a vaginal ring containing dapivirine for HIV-1 prevention in women.
Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506110 · Cited by 772
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., Kremer, G., Nogueira, L., Braunschweig, M., Scheid, J. F., et al. (2015) · Nature · doi:10.1038/nature14411 · Cited by 767
Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel
Yeni, P. G., Hammer, S. M., Hirsch, M. S., Saag, M. S., Schechter, M., Carpenter, C. C. J., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Jacobsen, D. M., et al. (2004) · JAMA · doi:10.1001/jama.292.2.251 · Cited by 737
Self-citationCarpenter, C. C. J. (1997) · JAMA · doi:10.1001/jama.1997.03540480062040 · Cited by 725
Thompson, M. A., Aberg, J. A., Cahn, P., Montaner, J. S. G., Rizzardini, G., Telenti, A., Gatell, J. M., Günthard, H. F., Hammer, S. M., Hirsch, M. S., et al. (2010) · JAMA · doi:10.1001/jama.2010.1004 · Cited by 722
Self-citationYeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., et al. (2002) · JAMA · doi:10.1001/jama.288.2.222 · Cited by 709
Self-citationQin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232688199 · Cited by 701
Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
Blanc, F.-X., Sok, T., Laureillard, D., Borand, L., Rekacewicz, C., Nerrienet, E., Madec, Y., Marcy, O., Chan, S., Prak, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013911 · Cited by 612
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Sax, P. E., Wohl, D., Yin, M. T., Post, F., DeJesus, E., Saag, M., Pozniak, A., Thompson, M., Podzamczer, D., Molina, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60616-x · Cited by 601
Self-citationThompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Self-citationHuman Immunodeficiency Virus Transmission at Each Step of the Care Continuum in the United States
Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., Fagan, J. L., Lansky, A., & Mermin, J. H. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8180 · Cited by 550
Raffi, F., Rachlis, A., Stellbrink, H.-J., Hardy, W. D., Torti, C., Orkin, C., Bloch, M., Podzamczer, D., Pokrovsky, V., Pulido, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61853-4 · Cited by 548
Carpenter, C. C. J. (1996) · JAMA · doi:10.1001/jama.276.2.146 · Cited by 541
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Havlir, D. V., Kendall, M. A., Ive, P., Kumwenda, J., Swindells, S., Qasba, S. S., Luetkemeyer, A. F., Hogg, E., Rooney, J. F., Wu, X., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013607 · Cited by 532
Cahn, P., Pozniak, A. L., Mingrone, H., Shuldyakov, A., Brites, C., Andrade-Villanueva, J. F., Richmond, G., Buendia, C. B., Fourie, J., Ramgopal, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61221-0 · Cited by 516
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Freedberg, K. A., Losina, E., Weinstein, M. C., Paltiel, A. D., Cohen, C. J., Seage, G. R., Craven, D. E., Zhang, H., Kimmel, A. D., & Goldie, S. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441108 · Cited by 508
Clotet, B., Feinberg, J., van Lunzen, J., Khuong-Josses, M.-A., Antinori, A., Dumitru, I., Pokrovskiy, V., Fehr, J., Ortiz, R., Saag, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60084-2 · Cited by 507
Self-citationTiming of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
Boulware, D. R., Meya, D. B., Muzoora, C., Rolfes, M. A., Huppler Hullsiek, K., Musubire, A., Taseera, K., Nabeta, H. W., Schutz, C., Williams, D. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312884 · Cited by 497
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 496
Self-citationGrinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Self-citationVolk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ778 · Cited by 489
The Periodic Health Examination
(1934) · New England Journal of Medicine · doi:10.1056/nejm193401252100413 · Cited by 483
Gardner, L. I., Metsch, L. R., Anderson-Mahoney, P., Loughlin, A. M., Rio, C. D., Strathdee, S., Sansom, S. L., Siegal, H. A., Greenberg, A. E., & Holmberg, S. D. (2005) · AIDS · doi:10.1097/01.aids.0000161772.51900.eb · Cited by 467
Lynch, R. M., Boritz, E., Coates, E. E., DeZure, A., Madden, P., Costner, P., Enama, M. E., Plummer, S., Holman, L., Hendel, C. S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5752 · Cited by 465
Günthard, H. F., Aberg, J. A., Eron, J. J., Hoy, J. F., Telenti, A., Benson, C. A., Burger, D. M., Cahn, P., Gallant, J. E., Glesby, M. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.8722 · Cited by 449
Self-citationSafren, S. A., O'Cleirigh, C., Tan, J. Y., Raminani, S. R., Reilly, L. C., Otto, M. W., & Mayer, K. H. (2009) · Health Psychology · doi:10.1037/a0012715 · Cited by 395
A CASE-CONTROL STUDY OF HIV SEROCONVERSION IN HEALTH CARE WORKERS AFTER PERCUTANEOUS EXPOSURE
Ardo, M. C., Ulver, D. A. H. C., Iesielski, C. A. A. C., Amela, P., Arcus, R. U. M., Biteboul, D. O. A., Eptonstall, J. U. H., L, F. L., Ibben, P. E. S. M. C. K., & Ell, D. A. M. B. (1997) · Cited by 383
Raffi, F., Jaeger, H., Quiros-Roldan, E., Albrecht, H., Belonosova, E., Gatell, J. M., Baril, J.-G., Domingo, P., Brennan, C., Almond, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70257-3 · Cited by 379
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Kiweewa, F. M., Nair, G., Mhlanga, F., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000489577.60775.40 · Cited by 372
HIV System Navigation: An Emerging Model to Improve HIV Care Access
Bradford, J. B., Coleman, S., & Cunningham, W. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.9987 · Cited by 334
Eron, J. J., Young, B., Cooper, D. A., Youle, M., DeJesus, E., Andrade-Villanueva, J., Workman, C., Zajdenverg, R., Fätkenheuer, G., Berger, D. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62041-9 · Cited by 317
Self-citationHammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M., Carpenter, C. C. J., Fischl, M. A., Gazzard, B., et al. (2006) · PubMed · Cited by 315
Self-citationAnanworanich, J., Schuetz, A., Vandergeeten, C., Sereti, I., de Souza, M., Rerknimitr, R., Dewar, R., Marovich, M., van Griensven, F., Sekaly, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033948 · Cited by 314
Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
Sax, P. E., Tierney, C., Collier, A. C., Fischl, M. A., Mollan, K., Peeples, L., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906768 · Cited by 313
Self-citationLucas, G. M., Ross, M. J., Stock, P. G., Shlipak, M. G., Wyatt, C. M., Gupta, S. K., Atta, M. G., Wools-Kaloustian, K. K., Pham, P. A., Bruggeman, L. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu617 · Cited by 310
Mills, A., Arribas, J. R., Andrade-Villanueva, J., DiPerri, G., Van Lunzen, J., Koenig, E., Elion, R., Cavassini, M., Madruga, J. V., Brunetta, J., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00348-5 · Cited by 302
Cottrell, M. L., Yang, K. H., Prince, H. M. A., Sykes, C., White, N., Malone, S., Dellon, E. S., Madanick, R. D., Shaheen, N. J., Hudgens, M. G., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw077 · Cited by 300
The periodic health examination. Canadian Task Force on the Periodic Health Examination.
(1979) · PubMed · Cited by 300
Buzon, M. J., Martin-Gayo, E., Pereyra, F., Ouyang, Z., Sun, H., Li, J. Z., Piovoso, M., Shaw, A., Dalmau, J., Zangger, N., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01046-14 · Cited by 277
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit757 · Cited by 268
Self-citationDepression Treatment Enhances Adherence to Antiretroviral Therapy: a Meta-Analysis
Sin, N. L., & DiMatteo, M. R. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9559-6 · Cited by 266
Schuetz, A., Deleage, C., Sereti, I., Rerknimitr, R., Phanuphak, N., Phuang-Ngern, Y., Estes, J. D., Sandler, N. G., Sukhumvittaya, S., Marovich, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004543 · Cited by 262
Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis
Marks, G., Gardner, L. I., Craw, J., & Crepaz, N. (2010) · AIDS · doi:10.1097/qad.0b013e32833f4b1b · Cited by 233
Walmsley, S., Baumgarten, A., Berenguer, J., Felizarta, F., Florence, E., Khuong-Josses, M.-A., Kilby, J. M., Lutz, T., Podzamczer, D., Portilla, J., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000790 · Cited by 227
Safren, S. A., O'Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028208 · Cited by 220
Post, F. A., Moyle, G. J., Stellbrink, H. J., Domingo, P., Podzamczer, D., Fisher, M., Norden, A. G., Cavassini, M., Rieger, A., Khuong-Josses, M.-A., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181dd911e · Cited by 216
Mollan, K. R., Smurzynski, M., Eron, J. J., Daar, E. S., Campbell, T. B., Sax, P. E., Gulick, R. M., Na, L., O'Keefe, L., Robertson, K. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0293 · Cited by 211
Self-citationA national review of vertical HIV transmission
Forbes, J. C., Alimenti, A. M., Singer, J., Brophy, J. C., Bitnun, A., Samson, L. M., Money, D. M., Lee, T. C. K., Lapointe, N. D., & Read, S. E. (2012) · AIDS · doi:10.1097/qad.0b013e328350995c · Cited by 207
Margolis, D. A., Brinson, C. C., Smith, G. H. R., de Vente, J., Hagins, D. P., Eron, J. J., Griffith, S. K., Clair, M. H. S., Stevens, M. C., Williams, P. E., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00152-8 · Cited by 204
Self-citationSiedner, M. J., Ng, C. K., Bassett, I. V., Katz, I. T., Bangsberg, D. R., & Tsai, A. C. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1137 · Cited by 202
Jereb, J., GOLDBERG, S. V., Powell, K. M., Villarino, M. E., & LoBue, P. A. (2011) · Cited by 199
Mocroft, A., Lundgren, J. D., Ross, M., Fux, C. A., Reiss, P., Moranne, O., Morlat, P., Monforte, A. D., Kirk, O., & Ryom, L. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(15)00211-8 · Cited by 198
Dooley, K. E., Sayre, P., Borland, J., Purdy, E., Chen, S., Song, I. H., Peppercorn, A., Everts, S., Piscitelli, S. C., & Flexner, C. W. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318276cda9 · Cited by 190
Wohl, D., Oka, S., Clumeck, N., Clarke, A., Brinson, C., Stephens, J., Tashima, K., Arribas, J. R., Rashbaum, B., Cheret, A., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000940 · Cited by 180
Self-citationRaffi, F., Babiker, A. G., Richert, L., Molina, J.-M., George, E. C., Antinori, A., Arribas, J. R., Grarup, J., Hudson, F., Schwimmer, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61170-3 · Cited by 179
Mugavero, M. J., Westfall, A. O., Cole, S. R., Geng, E. H., Crane, H. M., Kitahata, M. M., Mathews, W. C., Napravnik, S., Eron, J. J., Moore, R. D., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu603 · Cited by 173
Self-citationGallant, J. E., Daar, E. S., Raffi, F., Brinson, C., Ruane, P., DeJesus, E., Johnson, M., Clumeck, N., Osiyemi, O., Ward, D., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)00024-2 · Cited by 165
Self-citationSterling, T. R., Scott, N. A., Miro, J. M., Calvet, G., La Rosa, A., Infante, R., Chen, M. P., Benator, D. A., Gordin, F., Benson, C. A., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001098 · Cited by 165
Self-citationLiu, A. Y., Vittinghoff, E., Sellmeyer, D. E., Irvin, R., Mulligan, K., Mayer, K., Thompson, M., Grant, R., Pathak, S., O'Hara, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023688 · Cited by 160
Self-citationHofstra, L. M., Sauvageot, N., Albert, J., Alexiev, I., García, F., Struck, D., van de Vijver, D. A. M. C., Åsjö, B., Beshkov, D., Coughlan, S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ963 · Cited by 160
Feldman, B. J., Fredericksen, R. J., Crane, P. K., Safren, S. A., Mugavero, M. J., Willig, J. H., Simoni, J. M., Wilson, I. B., Saag, M. S., Kitahata, M. M., et al. (2013) · AIDS and Behavior · doi:10.1007/s10461-012-0326-7 · Cited by 159
Self-citationDistribution of Health Care Expenditures for HIV-Infected Patients
Chen, R. Y., Accortt, N. A., Westfall, A. O., Mugavero, M. J., Raper, J. L., Cloud, G. A., Stone, B. K., Carter, J., Call, S., Pisu, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/500453 · Cited by 153
Self-citationRyscavage, P., Kelly, S. G., Li, J. Z., Harrigan, P. R., & Taiwo, B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00076-14 · Cited by 147
Solomon, M. M., Lama, J. R., Glidden, D. V., Mulligan, K. M., McMahan, V., Liu, A., Guanira, J. V., Veloso, V. G., Mayer, K. H., Chariyalertsak, S., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000156 · Cited by 140
Laanani, M., Ghosn, J., Essat, A., Mélard, A., Seng, R., Gousset, M., Panjo, H., Mortier, E., Girard, P., Goujard, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ171 · Cited by 139
Marrazzo, J. M., del Río, C., Holtgräve, D. R., Cohen, M. S., Kalichman, S. C., Mayer, K. H., Montaner, J. S. G., Wheeler, D. P., Grant, R. M., Grinsztejn, B. G. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.7999 · Cited by 135
Self-citationPérez-Molina, J. A., Rubio, R., Rivero, A., Pasquau, J., Suárez-Lozano, I., Riera, M., Estébanez, M., Santos, J., Sanz, J., Troya, J., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00097-3 · Cited by 132
Effectiveness of Collaborative Care for Depression in Human Immunodeficiency Virus Clinics
Pyne, J. M., Fortney, J. C., Curran, G. M., Tripathi, S., Atkinson, J. H., Kilbourne, A. M., Hagedorn, H. J., Rimland, D., Rodriguez-Barradas, M. C., Monson, T., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.395 · Cited by 132
Walensky, R. P., Sax, P. E., Nakamura, Y., Weinstein, M. C., Pei, P. P., Freedberg, K. A., Paltiel, A. D., & Schackman, B. R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-2-201301150-00002 · Cited by 131
Self-citationCrowell, T. A., Gebo, K. A., Blankson, J. N., Korthuis, P. T., Yehia, B. R., Rutstein, R. M., Moore, R. D., Sharp, V., Nijhawan, A. E., Mathews, W. C., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu809 · Cited by 129
Friedland, G. H., Khoo, S., Jack, C., & Lalloo, U. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl399 · Cited by 120
for the D:A:D Study Group, Sabin, C. A., Reiss, P., Ryom, L., Phillips, A. N., Weber, R. K., Law, M. G., Fontas, É., Mocroft, A., Wit, S. D., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0588-4 · Cited by 119
Arribas, J. R., Pialoux, G., Gathe, J., Perri, G. D., Reynes, J., Tebas, P., Nguyen, T., Ebrahimi, R., White, K., & Piontkowsky, D. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70782-0 · Cited by 117
The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) (2010) · Clinical Infectious Diseases · doi:10.1086/655761 · Cited by 112
Chéret, A., Bacchus, C., Avettand-Fènoël, V., Mélard, A., Nembot, G., Blanc, C., Samri, A., Sáez‐Cirión, A., Hocqueloux, L., Lascoux‐Combe, C., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv084 · Cited by 111
Retention in Care of Persons Newly Diagnosed with HIV: Outcomes of the Outreach Initiative
Naar‐King, S., Bradford, J., Coleman, S. M., Green-Jones, M., Cabral, H., & Tobias, C. R. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.9988 · Cited by 109
Cahn, P. E., Rolón, M. J., Figueroa, M. I., Gun, A., Patterson, P., & Sued, O. G. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.01.21678 · Cited by 105
Mugwanya, K. K., Wyatt, C. M., Celum, C., Donnell, D. J., Mugo, N., Tappero, J. W., Kiarie, J. N., Ronald, A., & Baeten, J. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6786 · Cited by 103
Simoni, J. M., Wiebe, J. S., Sauceda, J. A., Huh, D., Sánchez, G., Longoria, V., Bedoya, C. A., & Safren, S. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0538-5 · Cited by 103
Mfinanga, S., Kirenga, B., Chanda, D. M., Mutayoba, B. K., Mthiyane, T., Yimer, G., Ezechi, O., Connolly, C., Kapotwe, V., Muwonge, C., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70733-9 · Cited by 103
Berg, K. M., Litwin, A. H., Li, X., Heo, M., & Arnsten, J. H. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.025 · Cited by 100
Boulanger, C., Hollender, E. S., Farrell, K., Stambaugh, J. J., Maasen, D., Ashkin, D., Symes, S. N., Espinoza, L. A., Rivero, R. O., Graham, J. J., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/606056 · Cited by 100
Grinsztejn, B. G. J., Castro, N. D., Arnold, V., Veloso, V. G., Morgado, M. G., Pilotto, J. H., Brites, C. R., Madruga, J. V., Barcellos, N. T., Santos, B. R., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70711-x · Cited by 99
(2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6517a5 · Cited by 96
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study
Champenois, K., Cousien, A., Cuzin, L., Vu, S. L., Deuffic‐Burban, S., Lanoy, É., Lacombe, K., Patey, O., Béchu, P., Calvez, M., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-200 · Cited by 94
Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals
Marcus, J. L., Neugebauer, R. S., Leyden, W. A., Chao, C., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000881 · Cited by 94
Young, J., Xiao, Y., Moodie, E. E. M., Abrahamowicz, M., Klein, M. B., Bernasconi, E., Schmid, P., Calmy, A., Cavassini, M. L., Cusini, A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000662 · Cited by 91
Volberding, P. A., Aberg, J. A., Eron, J. J., Telenti, A., Jacobsen, D. M., Thomas, D. L., Reiss, P., Günthard, H. F., Gallant, J. E., Cahn, P., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/yr7m-f297 · Cited by 91
Self-citationBroadly Neutralizing Antibodies for HIV Eradication
Stephenson, K. E., & Barouch, D. H. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0299-7 · Cited by 89
Kasonde, M., Niska, R. W., Rose, C. E., Henderson, F. L., Segolodi, T. M., Turner, K., Smith, D. K., Thigpen, M. C., & Paxton, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090111 · Cited by 84
Self-citationOfotokun, I., Na, L. H., Landovitz, R. J., Ribaudo, H. J., McComsey, G. A., Godfrey, C. C., Aweeka, F. T., Cohn, S. E., Sagar, M., Kuritzkes, D. R., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ193 · Cited by 83
Self-citationWolstein, O., Boyd, M. P., Millington, M., Impey, H., Boyer, J., Howe, A., Delebecque, F., Cornetta, K. G., Rothe, M., Baum, C., et al. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2013.11 · Cited by 82
Pence, B. W., Gaynes, B. N., Adams, J., Thielman, N. M., Heine, A. D., Mugavero, M. J., McGuinness, T. M., Raper, J. L., Willig, J. H., Shirey, K., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000797 · Cited by 82
Self-citationHIV therapeutic vaccines: moving towards a functional cure
Mylvaganam, G., Silvestri, G., & Amara, R. R. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.05.001 · Cited by 79
Manzardo, C., Guardo, A. C., Letang, E., Plana, M., Gatell, J. M., & Miró, J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1029917 · Cited by 79
Tsai, A. C., Karasic, D. H., Hammer, G. P., Charlebois, E. D., Ragland, K., Moss, A. R., Sorensen, J. L., Dilley, J., & Bangsberg, D. R. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300422 · Cited by 77
Lesko, C. R., Cole, S. R., Zinski, A., Poole, C., & Mugavero, M. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit421 · Cited by 77
Self-citationThe HIV care cascade in Switzerland
Kohler, P. P., Schmidt, A. J., Cavassini, M. L., Furrer, H., Calmy, A., Battegay, M., Bernasconi, E., Ledergerber, B., & Vernazza, P. (2015) · AIDS · doi:10.1097/qad.0000000000000878 · Cited by 75
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality
Glass, T. R., Sterne, J. A. C., Schneider, M. P., Geest, S. D., Nicca, D., Furrer, H., Günthard, H. F., Bernasconi, E., Calmy, A., Rickenbach, M., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000782 · Cited by 75
Self-citationDirectly Observed Therapy to Treat HIV Infection in Prisoners
Fontanarosa, P. B., Babudieri, S., Aceti, A., et al. (2000) · JAMA · doi:10.1001/jama.284.2.179 · Cited by 74
Magnus, M., Herwehe, J., Gruber, D., Wilbright, W., Shepard, E., Abrams, A., Foxhood, J., Smith, L., Xiao, K., DeYoung, K., et al. (2012) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2012.06.005 · Cited by 73
Burke, B. P., Levin, B. R., Zhang, J., Sahakyan, A., Boyer, J., Carroll, M. V., Colón, J. C., Keech, N., Rezek, V. K., Bristol, G. C., et al. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.10 · Cited by 72
Djawe, K., Buchacz, K. A., Hsu, L. C., Chen, M.-J., Selik, R. M., Rose, C. E., Williams, T., Brooks, J. T., & Schwarcz, S. K. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv235 · Cited by 70
Girouard, M. P., Sax, P. E., Parker, R. A., Taiwo, B., Freedberg, K. A., Gulick, R. M., Weinstein, M. C., Paltiel, A. D., & Walensky, R. P. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ981 · Cited by 69
Self-citationMarzel, A., Shilaih, M., Yang, W.-L., Böni, J., Yerly, S., Klimkait, T., Aubert, V., Braun, D. L., Calmy, A., Furrer, H., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ732 · Cited by 64
Self-citationthe Opposites Attract Study Group, Bavinton, B. R., Jin, F., Prestage, G., Zablotska, I., Koelsch, K. K., Phanuphak, N., Grinsztejn, B. G. J., Cooper, D. A., Fairley, C. K., et al. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-917 · Cited by 57
HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program
Derache, A., Shin, H., Balamane, M., White, E., Israelski, D. M., Klausner, J. D., Freeman, A. H., & Katzenstein, D. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117430 · Cited by 55
Moldt, B., Le, K. M., Carnathan, D. G., Whitney, J. B., Schultz, N., Lewis, M. G., Borducchi, E. N., Smith, K. M., Mackel, J. J., Sweat, S. L., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001102 · Cited by 55
Boillat‐Blanco, N., Darling, K., Schöni-Affolter, F., Vuichard, D., Rougemont, M., Fulchini, R., Bernasconi, E., Aouri, M., Clerc, O., Furrer, H., et al. (2014) · Antiviral Therapy · doi:10.3851/imp2815 · Cited by 54
Self-citationGaynes, B. N., Pence, B. W., Atashili, J., O’Donnell, J. K., NJAMNSHI, A. K., Tabenyang, M. E., Kefie, C., Whetten, R., Whetten, K., & Ndumbe, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140001 · Cited by 54
The causal effect of opioid substitution treatment on HAART medication refill adherence
Nosyk, B., Min, J. E., Colley, G., Lima, V. D., Yip, B., Milloy, M., Wood, E., & Montaner, J. S. G. (2015) · AIDS · doi:10.1097/qad.0000000000000642 · Cited by 47
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study
Scherrer, A., Yang, W.-L., Kouyos, R. D., Böni, J., Yerly, S., Klimkait, T., Aubert, V., Cavassini, M. L., Battegay, M., Hauser, C., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw165 · Cited by 45
Self-citationJenny-Avital, E. R., & Joseph, K. (2009) · Clinical Infectious Diseases · doi:10.1086/598336 · Cited by 43
Maru, D., Bruce, R. D., Walton, M. R., Springer, S. A., & Altice, F. L. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181938e7e · Cited by 41
Elion, R., Molina, J., Arribas, J. R., Cooper, D. A., Maggiolo, F., Wilkins, E., Conway, B., Liu, Y.-P., Margot, N., Rhee, M. S., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318298469c · Cited by 41
Study, T. S. H. C., Young, J., Rickenbach, M., Calmy, A., Bernasconi, E., Staehelin, C., Schmid, P., Cavassini, M. L., Battegay, M., Günthard, H. F., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1120-8 · Cited by 38
Self-citationProviral DNA as a Target for HIV-1 Resistance Analysis
Lübke, N., Cristanziano, V. D., Sierra, S., Knops, E., Schülter, E., Jensen, B., Oette, M., Lengauer, T., Kaiser, R., & on behalf of the Resina Study Group (2015) · Intervirology · doi:10.1159/000431093 · Cited by 33
Kovari, H., Sabin, C. A., Ledergerber, B., Ryom, L., Reiss, P., Law, M. G., Pradier, C., Dabis, F., Monforte, A. D., Smith, C. J., et al. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw009 · Cited by 31
Yangco, B. G., Buchacz, K. A., Baker, R. K., Palella, F. J., Armon, C., Brooks, J. T., & the HIV Outpatient Study Investigators (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0270 · Cited by 21
Cited by
Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA · doi:10.1001/jama.2018.8431 · Cited by 698
Self-citationMayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31065-5 · Cited by 428
Self-citation2015 update of the drug resistance mutations in HIV-1
Wensing, A. M. J., Cálvez, V., Ceccherini‐Silberstein, F., Charpentier, C., Günthard, H. F., Jacobsen, D. M., Paredes, R., Shafer, R. W., & Richman, D. D. (2015) · PubMed · doi:10.5167/uzh-122257 · Cited by 415
Self-citationSax, P. E., Pozniak, A., Montes, M. L., Koenig, E., DeJesus, E., Stellbrink, H.-J., Antinori, A., Workowski, K., Slim, J., Reynes, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32340-1 · Cited by 396
Self-citationGallant, J., Lazzarin, A., Mills, A., Orkin, C., Podzamczer, D., Tebas, P., Girard, P.-M., Brar, I., Daar, E. S., Wohl, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32299-7 · Cited by 393
Self-citation
Metadata
- Authors
- Günthard, H. F., Saag, M. S., Benson, C. A., del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., Gandhi, R. T., Landovitz, R. J., Smith, D. M., Jacobsen, D. M., & Volberding, P. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-07-12
- Volume
- 316
- Issue
- 2
- Pages
- 191
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2467247336
- Cited by
- 656
- References
- 153
- FWCI
- 106.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.